Product Description
Overall, the global coronary intravascular lithotripsy device market was valued at over $1.9 billion in 2025. This is expected to increase over the forecast period at a CAGR of 6.0% to reach nearly $2.9 billion.
The full report suite on the global market for coronary intravascular lithotripsy (IVL) device includes catheter-based systems that deliver sonic pressure waves inside coronary arteries to fracture calcified plaque and improve vessel compliance before stent implantation.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Coronary Intravascular Lithotripsy Device Market Trends
Since its approval in 2021, IVL has become a highly studied medical therapy. Numerous long-term clinical studies are ongoing, and new devices are in development. As a result, the market is rapidly evolving from a small, niche segment into a broader, global one.
Global Coronary Intravascular Lithotripsy Device Market Share Insights
- ShockWave Medical is the leading company in the IVL device marketin 2025, having been the first to enter the space in 2021 and maintaining a dominant position globally. Given the high costs associated with developing IVL technology, the company is expected to retain its market leadership throughout the forecast period.
- Microport is a notable competitor in the IVL device market. Following the approval of its IVL system in China in 2025, the company is expected to challenge ShockWave Medical’s dominance in the Asia-Pacific region. However, its overall presence in the market remains limited, leaving little room for significant market share expansion over the forecast period.
Global Coronary Intravascular Lithotripsy Device Market Segmentation Summary
- Coronary Intravascular Lithotripsy
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
